Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somavaratan in pediatric growth hormone deficiency
NCT01718041Phase 2Completed
- Sponsor
- Versartis, Inc.
- Start
- Oct 2012
- Primary completion
- Jul 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of somavaratan in growth hormone deficiency (GHD), sponsored by Versartis, Inc.. Started Oct 2012; status: completed.
02
Drugs
somavaratan
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01718041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718041.